Your request to link to rcsb for Acetylcholinesterase


  • 1CFJ: methylphosphonylated acetylcholinesterase (aged) obtained by reaction with o-isopropylmethylphosphonofluoridate (gb, sarin) (10.1021/BI982678L )
  • 1DX6: structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3a resolution (10.1016/S0014-5793(99)01637-3 )
  • 1E3Q: torpedo californica acetylcholinesterase complexed with bw284c51 (10.1107/S0907444902011642 )
  • 1E66: structure of acetylcholinesterase complexed with (-)-huprine x at 2.1a resolution (10.1021/BI011652I )
  • 1EA5: native acetylcholinesterase (e.c. 3.1.1.7) from torpedo californica at 1.8a resolution (10.1021/BI020151+ )
  • 1EEA: acetylcholinesterase
  • 1EVE: three dimensional structure of the anti-alzheimer drug, e2020 (aricept), complexed with its target acetylcholinesterase (10.1016/S0969-2126(99)80040-9 )
  • 1FSS: acetylcholinesterase (e.c. 3.1.1.7) complexed with fasciculin-ii (10.1016/S0969-2126(01)00273-8 )
  • 1GPK: structure of acetylcholinesterase complex with (+)-huperzine a at 2.1a resolution (10.1021/BI020151+ )
  • 1GPN: structure of acetylcholinesterase complexed with huperzine b at 2.35a resolution (10.1021/BI020151+ )
  • 1GQR: acetylcholinesterase (e.c. 3.1.1.7) complexed with rivastigmine (10.1021/BI020016X )
  • 1GQS: acetylcholinesterase (e.c. 3.1.1.7) complexed with nap (10.1021/BI020016X )
  • 1H22: structure of acetylcholinesterase (e.c. 3.1.1.7) complexed with (s,s)- (-)-bis(10)-hupyridone at 2.15a resolution (10.1021/JA021111W )
  • 1H23: structure of acetylcholinesterase (e.c. 3.1.1.7) complexed with (s,s)- (-)-bis(12)-hupyridone at 2.15a resolution (10.1021/JA021111W )
  • 1HBJ: x-ray crystal structure of complex between torpedo californica ache and a reversible inhibitor, 4-amino-5-fluoro-2-methyl-3-(3- trifluoroacetylbenzylthiomethyl)quinoline (10.1021/JM010826R )
  • 1JJB: a neutral molecule in cation-binding site: specific binding of peg-sh to acetylcholinesterase from torpedo californica (10.1016/S0022-2836(02)00475-8 )
  • 1OCE: acetylcholinesterase (e.c. 3.1.1.7) complexed with mf268 (10.1021/BI982723P )
  • 1ODC: structure of acetylcholinesterase (e.c. 3.1.1.7) complexed with n-4'- quinolyl-n'-9"-(1",2",3",4"-tetrahydroacridinyl)-1,8- diaminooctane at 2.2a resolution (10.1021/JM060164B )
  • 1QID: specific chemical and structural damage at nine time points (point a) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QIE: specific chemical and structural damage at nine time points (point b) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QIF: specific chemical and structural damage at nine time points (point c) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QIG: specific chemical and structural damage at nine time points (point d) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QIH: specific chemical and structural damage at nine time points (point e) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QII: specific chemical and structural damage at nine time points (point f) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QIJ: specific chemical and structural damage at nine time points (point g) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QIK: specific chemical and structural damage at nine time points (point h) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QIM: specific chemical and structural damage at nine time points (point i) caused by intense synchrotron radiation to torpedo californica acetylcholinesterase (10.1073/PNAS.97.2.623 )
  • 1QTI: acetylcholinesterase (e.c.3.1.1.7)
  • 1SOM: torpedo californica acetylcholinesterase inhibited by nerve agent gd (soman). (10.1021/BI982678L )
  • 1U65: ache w. cpt-11 (10.1124/MOL.104.009944 )
  • 1UT6: structure of acetylcholinesterase (e.c. 3.1.1.7) complexed with n-9- (1',2',3',4'-tetrahydroacridinyl)-1,8- diaminooctane at 2.4 angstroms resolution. (10.1021/JM060164B )
  • 1VOT: acetylcholinesterase (e.c. 3.1.1.7) complexed with huperzine a (10.1038/NSB0197-57 )
  • 1VXO: methylphosphonylated acetylcholinesterase (aged) obtained by reaction with o-ethyl-s-[2-[bis(1-methylethyl)amino]ethyl] methylphosphonothioate (vx) (10.1021/JA992704I )
  • 1VXR: o-ethylmethylphosphonylated acetylcholinesterase obtained by reaction with o-ethyl-s-[2-[bis(1-methylethyl)amino]ethyl] methylphosphonothioate (vx) (10.1021/JA992704I )
  • 1W4L: complex of tcache with bis-acting galanthamine derivative (10.1021/JA0466154 )
  • 1W6R: complex of tcache with galanthamine derivative (10.1021/JA0466154 )
  • 1W75: native orthorhombic form of torpedo californica acetylcholinesterase (ache) (10.1021/JA0466154 )
  • 1W76: orthorhombic form of torpedo californica acetylcholinesterase (ache) complexed with bis-acting galanthamine derivative (10.1021/JA0466154 )
  • 1ZGB: crystal structure of torpedo californica acetylcholinesterase in complex with an (r)-tacrine(10)-hupyridone inhibitor. (10.1021/JA051765F )
  • 1ZGC: crystal structure of torpedo californica acetylcholinesterase in complex with an (rs)-tacrine(10)-hupyridone inhibitor. (10.1021/JA051765F )
  • 2ACE: native acetylcholinesterase (e.c. 3.1.1.7) from torpedo californica (10.1038/NSB0197-57 )
  • 2ACK: acetylcholinesterase complexed with edrophonium, monochromatic data (10.1107/S0907444998005277 )
  • 2BAG: 3d structure of torpedo californica acetylcholinesterase complexed with ganstigmine (10.1021/JM060293S )
  • 2C4H: torpedo californica acetylcholinesterase in complex with 500mm acetylthiocholine (10.1038/SJ.EMBOJ.7601175 )
  • 2C58: torpedo californica acetylcholinesterase in complex with 20mm acetylthiocholine (10.1038/SJ.EMBOJ.7601175 )
  • 2C5F: torpedo californica acetylcholinesterase in complex with a non hydrolysable substrate analogue, 4-oxo-n,n,n-trimethylpentanaminium (10.1038/SJ.EMBOJ.7601175 )
  • 2C5G: torpedo californica acetylcholinesterase in complex with 20mm thiocholine (10.1038/SJ.EMBOJ.7601175 )
  • 2CEK: conformational flexibility in the peripheral site of torpedo californica acetylcholinesterase revealed by the complex structure with a bifunctional inhibitor (10.1021/JA058683B )
  • 2CKM: torpedo californica acetylcholinesterase complexed with alkylene- linked bis-tacrine dimer (7 carbon linker) (10.1021/JM060164B )
  • 2CMF: torpedo californica acetylcholinesterase complexed with alkylene- linked bis-tacrine dimer (5 carbon linker) (10.1021/JM060164B )
  • 2DFP: x-ray structure of aged di-isopropyl-phosphoro-fluoridate (dfp) bound to acetylcholinesterase (10.1021/BI982678L )
  • 2J3D: native monoclinic form of torpedo acetylcholinesterase
  • 2J3Q: torpedo acetylcholinesterase complexed with fluorophore thioflavin t (10.1021/JA7109822 )
  • 2J4F: torpedo acetylcholinesterase - hg heavy-atom derivative (10.1021/BI00252A006 )
  • 2V96: structure of the unphotolysed complex of tcache with 1-(2- nitrophenyl)-2,2,2-trifluoroethyl-arsenocholine at 100k (10.1107/S0907444907044472 )
  • 2V97: structure of the unphotolysed complex of tcache with 1-(2- nitrophenyl)-2,2,2-trifluoroethyl-arsenocholine after a 9 seconds annealing to room temperature (10.1107/S0907444907044472 )
  • 2V98: structure of the complex of tcache with 1-(2-nitrophenyl)-2,2,2- trifluoroethyl-arsenocholine after a 9 seconds annealing to room temperature, during the first 5 seconds of which laser irradiation at 266nm took place (10.1107/S0907444907044472 )
  • 2VA9: structure of native tcache after a 9 seconds annealing to room temperature during the first 5 seconds of which laser irradiation at 266nm took place (10.1107/S0907444907044472 )
  • 2VJA: torpedo californica acetylcholinesterase in complex with a non hydrolysable substrate analogue, 4-oxo-n,n,n- trimethylpentanaminium - orthorhombic space group - dataset a at 100k (10.1073/PNAS.0804828105 )
  • 2VJB: torpedo californica acetylcholinesterase in complex with a non hydrolysable substrate analogue, 4-oxo-n,n,n- trimethylpentanaminium - orthorhombic space group - dataset d at 100k (10.1073/PNAS.0804828105 )
  • 2VJC: torpedo californica acetylcholinesterase in complex with a non hydrolysable substrate analogue, 4-oxo-n,n,n- trimethylpentanaminium - orthorhombic space group - dataset a at 150k (10.1073/PNAS.0804828105 )
  • 2VJD: torpedo californica acetylcholinesterase in complex with a non hydrolysable substrate analogue, 4-oxo-n,n,n- trimethylpentanaminium - orthorhombic space group - dataset c at 150k (10.1073/PNAS.0804828105 )
  • 2VQ6: torpedo californica acetylcholinesterase complexed with 2-pam
  • 2VT6: native torpedo californica acetylcholinesterase collected with a cumulated dose of 9400000 gy (10.1073/PNAS.0804828105 )
  • 2VT7: native torpedo californica acetylcholinesterase collected with a cumulated dose of 800000 gy (10.1073/PNAS.0804828105 )
  • 2W6C: ache in complex with a bis-(-)-nor-meptazinol derivative (10.1021/JM801657V )
  • 2WFZ: non-aged conjugate of torpedo californica acetylcholinesterase with soman (10.1021/JM900433T )
  • 2WG0: aged conjugate of torpedo californica acetylcholinesterase with soman (obtained by in crystallo aging) (10.1021/JM900433T )
  • 2WG1: ternary complex of the aged conjugate of torpedo californica aceylcholinesterase with soman and 2-pam (10.1021/JM900433T )
  • 2WG2: non-aged conjugate of torpedo californica acetylcholinesterase with soman (alternative refinement) (10.1021/JM900433T )
  • 2XI4: torpedo californica acetylcholinesterase in complex with aflatoxin b1 (orthorhombic space group) (10.1002/PRO.661 )
  • 3GEL: o-methylphosphorylated torpedo acetylcholinesterase obtained by reaction with methyl paraoxon (aged)
  • 3I6M: 3d structure of torpedo californica acetylcholinesterase complexed with n-piperidinopropyl-galanthamine (10.1021/JM901296P )
  • 3I6Z: 3d structure of torpedo californica acetylcholinesterase complexed with n-saccharinohexyl-galanthamine (10.1021/JM901296P )
  • 3M3D: crystal structure of acetylcholinesterase in complex with xenon
  • 3ZV7: torpedo californica acetylcholinesterase inhibition by bisnorcymserine (10.1042/BJ20111675 )
  • 4TVK: torpedo californica acetylcholinesterase in complex with a chlorotacrine-juglone hybrid inhibitor (10.1021/JM5010804 )
  • 4W63: torpedo californica acetylcholinesterase in complex with a tacrine- benzofuran hybrid inhibitor (10.1021/ACS.JMEDCHEM.5B01119 )
  • 4X3C: torpedo californica acetylcholinesterase in complex with a tacrine- nicotinamide hybrid inhibitor
  • 5BWB: acetylcholinesterase (e.c. 3.1.1.7) from torpedo californica in complex with the bis-imidazolium oxime 2bim-7 (10.1107/S1399004715011281 )
  • 5BWC: acetylcholinesterase (e.c. 3.1.1.7) from torpedo californica in complex with the bis-pyridinium oxime ortho-7 (10.1107/S1399004715011281 )
  • 5DLP: acetylcholinesterase methylene blue no peg 10-apr-19 5dlp 1 title (10.1002/PRO.2923 )
  • 5E2I: acetylcholinesterase methylene blue no peg 10-apr-19 5e2i 1 title (10.1002/PRO.2923 )
  • 5E4J: acetylcholinesterase methylene blue no peg 10-apr-19 5e4j 1 title (10.1002/PRO.2923 )
  • 5E4T: acetylcholinesterase methylene blue with peg 10-apr-19 5e4t 1 title (10.1002/PRO.2923 )
  • 5EHX: crystal structure of msf-aged torpedo californica acetylcholinesterase
  • 5EI5: crystal structure of msf-aged torpedo californica acetylcholinesterase in complex with alkylene-linked bis-tacrine dimer (7 carbon linker)
  • 5IH7: acetylcholinesterase of torpedo californica in complex with the n- methyl-indoxylacetate hydrolysis products
  • 5NAP: torpedo californica acetylcholinesterase in complex with a non-chiral donepezil-like inhibitor 17 (10.1080/14756366.2018.1458030 )
  • 5NAU: torpedo californica acetylcholinesterase in complex with a non-chiral donepezil-like compound 20 (10.1080/14756366.2018.1458030 )
  • 5NUU: torpedo californica acetylcholinesterase in complex with a chlorotacrine-tryptophan hybrid inhibitor (10.1016/J.EJMECH.2019.02.021 )
  • 6EUC: reactivating oxime bound to tc ache's catalytic gorge. (10.1002/CHEM.201801394 )
  • 6EUE: rivastigmine analogue bound to tc ache. (10.1038/S42004-019-0133-4 )
  • 6EWK: t. californica ache in complex with a 3-hydroxy-2-pyridine aldoxime. (10.1002/CHEM.201801394 )
  • 6EZG: torpedo californica ache in complex with indolic multi-target directed ligand (10.1016/J.EJMECH.2018.10.064 )
  • 6EZH: torpedo californica ache in complex with indolic multi-target directed ligand (10.1016/J.EJMECH.2018.10.064 )
  • 6FLD: carbamylated t. californica acetylcholineterase bound to uncharged hybrid reactivator 1 (10.1021/ACS.JMEDCHEM.8B00592 )
  • 6FQN: carbamylated t. californica acetylcholineterase bound to uncharged hybrid reactivator 2 (10.1021/ACS.JMEDCHEM.8B00592 )
  • 6G17: non-aged form of torpedo californica acetylcholinesterase inhibited by nerve agent tabun (10.1021/ACS.JMEDCHEM.8B00592 )
  • 6G1U: crystal structure of torpedo californica acetylcholinesterase in complex with 9-amino-6-chloro-1,2,3,4-tetrahydro-10-methylacridin-10- ium (10.3390/MOLECULES23030634 )
  • 6G1V: crystal structure of torpedo californica acetylcholinesterase in complex with 12-amino-3-chloro-6,7,10,11-tetrahydro-5,9-dimethyl-7, 11-methanocycloocta[b]quinolin-5-ium (10.3390/MOLECULES23030634 )
  • 6G1W: crystal structure of torpedo californica acetylcholinesterase in complex with 2-{1-[2-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino) ethyl]-1h-1,2,3-triazol-4-yl}-n-[4-(hydroxy)-3- methoxybenzyl]acetamide (10.3390/MOLECULES23030634 )
  • 6G4M: torpedo californica acetylcholinesterase bound to uncharged hybrid reactivator 1 (10.1021/ACS.JMEDCHEM.8B00592 )
  • 6G4N: torpedo californica acetylcholinesterase bound to uncharged hybrid reactivator 2 (10.1021/ACS.JMEDCHEM.8B00592 )
  • 6G4O: non-aged form of torpedo californica acetylcholinesterase inhibited by tabun analog nedpa bound to uncharged reactivator 1 (10.1021/ACS.JMEDCHEM.8B00592 )
  • 6G4P: non-aged form of torpedo californica acetylcholinesterase inhibited by tabun analog nedpa bound to uncharged reactivator 2 (10.1021/ACS.JMEDCHEM.8B00592 )
  • 6H12: crystal structure of tcache complexed to 1-(6-oxo-1,2,3,4,6,10b- hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(((1-(2-((1,2,3,4- tetrahydroacridin-9-yl)amino)ethyl)-1h-1,2,3-triazol-4-yl)methoxy) methyl)pyridin-2-yl)urea (10.1016/J.EJMECH.2018.12.063 )
  • 6H13: crystal structure of tcache complexed to1-(4-((methyl((1-(2-((1,2,3,4- tetrahydroacridin-9-yl)amino)ethyl)-1h-1,2,3-triazol-4-yl)methyl) amino)methyl)pyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2, 1-a]isoindol-10-yl)urea (10.1016/J.EJMECH.2018.12.063 )
  • 6H14: crystal structure of tcache complexed to 1-(6-oxo-1,2,3,4,6,10b- hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(1-(2-((1,2,3,4- tetrahydroacridin-9-yl)amino)ethyl)-1h-1,2,3-triazol-4-yl)pyridin-2- yl)urea (10.1016/J.EJMECH.2018.12.063 )
  • 6TT0: crystal structure of a potent and reversible dual binding site acetylcholinesterase chiral inhibitor (10.1021/ACSMEDCHEMLETT.9B00656 )
  • 7B2W: torpedo californica acetylcholinesterase complexed with uo2 (10.1002/PRO.4061 )
  • 7B38: torpedo californica acetylcholinesterase complexed with mg+2 (10.1002/PRO.4061 )
  • 7B8E: torpedo californica acetylcholinesterase complexed with ca+2 (10.1002/PRO.4061 )